M Cristofanilli, NC Turner, I Bondarenko, etal Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone receptor positive, HER2 negative metastatic breast cancer that progressed on previous endocrine therapy PALOMA 3 Final analysis of the multicentre, double blind, phase 3 randomised controlled trial Lancet Oncol 17 425 439, 2016
M Cristofanilli, NC Turner, I Bondarenko, etal Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone receptor positive, HER2 negative metastatic breast cancer that progressed on previous endocrine therapy PALOMA 3 Final analysis of the multicentre, double blind, phase 3 randomised controlled trial Lancet Oncol 17 425 439, 2016